Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Fridlyand

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Cancer Research|September 23, 2003
Genome-wide array CGH analysis of murine neuroblastoma reveals distinct genomic aberrations which parallel those in human tumorsChristopher S Hackett, J Graeme Hodgson, Mark E Law, et al.
Nature|July 6, 2012
Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitorsTimothy R Wilson, Jane Fridlyand, Yibing Yan, et al.
Genome Research|February 3, 2005
Mapping segmental and sequence variations among laboratory mice using BAC array CGHAntoine M Snijders, Norma J Nowak, Bing Huey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2012
Phosphoinositide 3-kinase (PI3K) pathway alterations are associated with histologic subtypes and are predictive of sensitivity to PI3K inhibitors in lung cancer preclinical modelsJill M Spoerke, Carol O'Brien, Ling Huw, et al.
Breast Cancer Research and Treatment|October 23, 2014
Development of a robust RNA-based classifier to accurately determine ER, PR, and HER2 status in breast cancer clinical samplesTimothy R Wilson, Yuanyuan Xiao, Jill M Spoerke, et al.
BMC Cancer|April 20, 2006
Breast tumor copy number aberration phenotypes and genomic instabilityJane Fridlyand, Antoine M Snijders, Bauke Ylstra, et al.
The American Journal of Pathology|February 25, 2003
High-resolution analysis of paraffin-embedded and formalin-fixed prostate tumors using comparative genomic hybridization to genomic microarraysPamela L Paris, Donna G Albertson, Janneke C Alers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancerYinghui Guan, Wen-Lin Kuo, Jackie L Stilwell, et al.
Molecular Cancer Therapeutics|May 2, 2006
Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panelKimberly J Bussey, Koei Chin, Samir Lababidi, et al.
NPJ Breast Cancer|July 20, 2017
The molecular landscape of high-risk early breast cancer: comprehensive biomarker analysis of a phase III adjuvant populationTimothy R Wilson, Jianjun Yu, Xuyang Lu, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Cancer Research|September 23, 2003
Genome-wide array CGH analysis of murine neuroblastoma reveals distinct genomic aberrations which parallel those in human tumorsChristopher S Hackett, J Graeme Hodgson, Mark E Law, et al.
Nature|July 6, 2012
Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitorsTimothy R Wilson, Jane Fridlyand, Yibing Yan, et al.
Genome Research|February 3, 2005
Mapping segmental and sequence variations among laboratory mice using BAC array CGHAntoine M Snijders, Norma J Nowak, Bing Huey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2012
Phosphoinositide 3-kinase (PI3K) pathway alterations are associated with histologic subtypes and are predictive of sensitivity to PI3K inhibitors in lung cancer preclinical modelsJill M Spoerke, Carol O'Brien, Ling Huw, et al.
Breast Cancer Research and Treatment|October 23, 2014
Development of a robust RNA-based classifier to accurately determine ER, PR, and HER2 status in breast cancer clinical samplesTimothy R Wilson, Yuanyuan Xiao, Jill M Spoerke, et al.
BMC Cancer|April 20, 2006
Breast tumor copy number aberration phenotypes and genomic instabilityJane Fridlyand, Antoine M Snijders, Bauke Ylstra, et al.
The American Journal of Pathology|February 25, 2003
High-resolution analysis of paraffin-embedded and formalin-fixed prostate tumors using comparative genomic hybridization to genomic microarraysPamela L Paris, Donna G Albertson, Janneke C Alers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancerYinghui Guan, Wen-Lin Kuo, Jackie L Stilwell, et al.
Molecular Cancer Therapeutics|May 2, 2006
Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panelKimberly J Bussey, Koei Chin, Samir Lababidi, et al.
NPJ Breast Cancer|July 20, 2017
The molecular landscape of high-risk early breast cancer: comprehensive biomarker analysis of a phase III adjuvant populationTimothy R Wilson, Jianjun Yu, Xuyang Lu, et al.
Pageof 6